Evofosfamide Versus Ifosfamide Patient Selection in Soft Tissue Sarcoma

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD, PhD; and Shreyaskumar Patel, MD, discuss patient selection and the role of evofosfamide in soft tissue sarcoma.

• Catégorie